Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate versus azathioprine in adults with severe chronic atopic dermatitis
NL-OMON33396Phase 3Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Jul 2009
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in atopic dermatitis (AD) comparing Methotrexate with Azathioprine (2 arms). Primary endpoints: Mean change in SCORAD at week 12, Mean change in IGA at week 12 and 2 more. Started Jul 2009; status: active, not recruiting.
02
Drugs
methotrexateazathioprine
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NL-OMON33396.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON33396.